Heping Li
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
Papers in
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Co-authors
- Jianting LongGuosheng TanQiangsheng DaiBinhui XieBing ZhangJianyong YangShiqiu XiongXiaonong Wang
- Journals
- Journal of Translational Medicine (3 papers)Scientific Reports (2 papers)Anti-Cancer Drugs (2 papers)BMC Cancer (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Heping Li
46 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Cancer Research 503
- Molecular Biology 755
- Hepatology 77
- Oncology 232
- Biomaterials 91
Countries citing papers authored by Heping Li
This map shows the geographic impact of Heping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heping Li more than expected).
Fields of papers citing papers by Heping Li
This network shows the impact of papers produced by Heping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heping Li. The network helps show where Heping Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Heping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 15 | |
| 8 | 2020 | 29 | |
| 9 | 2019 | 21 | |
| 10 | 2019 | 54 | |
| 11 | 2018 | 46 | |
| 12 | 2017 | 48 | |
| 13 | 2017 | 6 | |
| 14 | 2016 | 9 | |
| 15 | 2016 | 7 | |
| 16 | 2016 | 6 | |
| 17 | 2015 | 18 | |
| 18 | 2015 | 29 | |
| 19 | 2014 | 100 | |
| 20 | 2013 | 83 |
About Heping Li
Heping Li is a scholar working on Cancer Research, Hepatology, Oncology, Molecular Biology and Biophysics, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (6 papers), Cancer Mechanisms and Therapy (4 papers), Cancer Cells and Metastasis (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cancer Research (503 citations), Molecular Biology (755 citations), Hepatology (77 citations), Oncology (232 citations) and Biomaterials (91 citations). Heping Li has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Jianting Long, Guosheng Tan, Qiangsheng Dai, Binhui Xie, Bing Zhang, Jianyong Yang, Shiqiu Xiong, Xiaonong Wang, Ruifang Zeng and Bing Zhang. Their work appears in journals such as Journal of Translational Medicine, Scientific Reports, Anti-Cancer Drugs, BMC Cancer and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.